Literature DB >> 7706713

Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes.

M Ferrarini1, S Heltai, E Toninelli, M G Sabbadini, C Pellicciari, A A Manfredi.   

Abstract

A common feature of human V gamma 9/V delta 2 gamma delta T lymphocytes is their ability to kill Daudi lymphoma cells. We show here that during this killing a substantial fraction of cytotoxic gamma delta T cells dies as well. Their death has morphologic, cytometric, and biochemical features of apoptosis and depends on TCR triggering. We suggest that interaction with the target physiologically induces the programmed death of the cytotoxic gamma delta effector. The death of activated gamma delta T cells upon challenge with the relevant Ag may represent a negative feedback mechanism and contribute to explain the limited time span of gamma delta T cell expansions during infectious diseases, even when pathogens are not eliminated and persist in the host.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Gammadelta T cells as immune effectors against high-grade gliomas.

Authors:  Lawrence S Lamb
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 3.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy.

Authors:  F Martini; R Urso; C Gioia; A De Felici; P Narciso; A Amendola; M G Paglia; V Colizzi; F Poccia
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 5.  How tumors might withstand γδ T-cell attack.

Authors:  Aude-Hélène Capietto; Ludovic Martinet; Jean-Jacques Fournié
Journal:  Cell Mol Life Sci       Date:  2011-05-06       Impact factor: 9.261

6.  Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells.

Authors:  Elisabetta Ferrero; Priscilla Biswas; Katuscia Vettoretto; Marina Ferrarini; Mariagrazia Uguccioni; Luca Piali; Biagio Eugenio Leone; Bernhard Moser; Claudio Rugarli; Ruggero Pardi
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

7.  Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.

Authors:  Nichole L Bryant; Catalina Suarez-Cuervo; G Yancey Gillespie; James M Markert; L Burt Nabors; Sreelatha Meleth; Richard D Lopez; Lawrence S Lamb
Journal:  Neuro Oncol       Date:  2009-02-11       Impact factor: 12.300

8.  Inhibition of phosphoantigen-mediated gammadelta T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells.

Authors:  Volker Kunzmann; Brigitte Kimmel; Thomas Herrmann; Hermann Einsele; Martin Wilhelm
Journal:  Immunology       Date:  2008-09-02       Impact factor: 7.397

9.  Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.

Authors:  Hiranmoy Das; Zhihui Wang; M Khalid Khan Niazi; Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Metin Gurcan; Vittorio Cristini
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

10.  Linking innate and adaptive immunity: human Vgamma9Vdelta2 T cells enhance CD40 expression and HMGB-1 secretion.

Authors:  Shirin Kalyan; Anthony W Chow
Journal:  Mediators Inflamm       Date:  2009-10-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.